📚 PsyDin Research Database

← PsyDin Home
Showing 15 of 20167 papers

Opioid use disorder and dementia risk: evidence from observational and genetic analyses in diverse ancestry cohorts.

Authors: Javidnia S, Roe JM, Karhunen V, Gill D, Bell S, Deak JD, Levey D, Kember RL, Kranzler HR, Cronjé HT, Burgess S, Gelernter J, Ebmeier KP, Topiwala A

Alzheimer's & dementia : the journal of the Alzheimer's Association

psychopharmacology mental health open access

CB1 receptor signaling at the cingulate-striatal circuit is anxiogenic.

Authors: Kelly TJ, Liu X, Huang Y, Hu Y, Friedman V, Hillard CJ, Liu QS

Nature communications

psychopharmacology mental health open access

Systems-level investigation of the anxiolytic gut-brain interactions induced by paraprobiotic Lactobacillus brevis SBC8803 in zebrafish.

Authors: Kubota A, Zang L, Shinkai T, Nakai M, Tajima A, Shimada Y

Frontiers in microbiology

psychopharmacology mental health open access

A unified voice for evidence-based psychiatry: a global response to the WHO guidance on ECT.

Authors: Sartorius A, Zilles-Wegner D

European archives of psychiatry and clinical neuroscience

psychopharmacology mental health open access

Machine learning-based computational validation of the Addictions Neuroclinical Assessment framework in relation to hazardous drinking.

Authors: Elsayed M, Belisario K, Murphy J, MacKillop J

Journal of psychiatry & neuroscience : JPN

psychopharmacology mental health open access

Ang II-mediated effects on BBB integrity in psychiatric and neurological disorders.

Authors: Hatho Towo DH, Jari I, Canivet C, Deslauriers J

Progress in neuro-psychopharmacology & biological psychiatry

psychopharmacology mental health open access

Unmasking Malignant Catatonia: A Diagnostic Challenge in a Febrile Patient With Altered Mental Status.

Authors: Lim YH, Yii IYL

Cureus

psychopharmacology mental health open access

Risk of extrapyramidal symptoms associated with antipsychotic drugs in children and adolescents: a systematic review and meta-analysis of double-blind randomised placebo-controlled trials.

Authors: Galvañ J, Distefano G, Echeverria I, Aymerich C, Abregú-Crespo R, Lorente MMA, Cruz N, López-Larriba L, Moreno D, Parellada M, Arango C, Pablo GS, Díaz-Caneja CM

Research square

psychopharmacology mental health open access

Clinical characteristics of auditory verbal hallucinations by spatial location: objective and subjective comparisons in schizophrenia.

Authors: Lho SK, Chung IW, Jeong SH, Kim SH, Kim YS, Jung HY

BMC psychiatry

psychopharmacology mental health open access

Ultra-high field magnetic resonance spectroscopy study of transcranial magnetic stimulation treatment in adolescents with depression.

Authors: Bakir CN, Genovese G, Nakonezny PA, Azamet I, Shekunov J, Voort JLV, Marjańska M, Croarkin PE

BMC psychiatry

psychopharmacology mental health open access

Treatment Patterns and Clinical Outcomes in Youth with Comorbid ADHD and PTSD: Insights from Real-World Data.

Authors: Baweja R, Lopes F, Padilla FM, Baweja R, Amaya-Jackson L, Waschbusch DA, Waxmonsky JG

Journal of attention disorders

psychopharmacology mental health open access

Prescribing factors influencing hospital length of stay in patients initiating lithium therapy for acute bipolar or schizoaffective mood episodes.

Authors: Cordell WG, Herbst C, Kelsey T, Melton BL, Moeller KE

The mental health clinician

psychopharmacology mental health open access

Board-certified psychiatric pharmacists in substance use disorder treatment: Integration, services, and outcomes across care settings.

Authors: Vallabh A, Abelleira A, Douglass AR, Gutierrez CA, Maister A, Miskle B, Moeller KE, Salwan A, Waters K, Dadiomov D

The mental health clinician

psychopharmacology mental health open access

"Homicide and Zonisamide": a review of the literature and illustrative case report on second and third generation antiseizure medications and psychiatric effects.

Authors: Nguyen S, Varkey TC, Khan B, Cornelius MC

Frontiers in psychiatry

psychopharmacology mental health open access

Identifying psychiatric comorbidities that occur following the introduction of hormonal contraception: a scoping review.

Authors: Poirier A, Fortier J, Marin MF, Désilets M, Hudon A

Frontiers in psychiatry

psychopharmacology mental health open access